CD68 and metabolic dysfunction-associated steatohepatitis: In addition, the number of CD68-labeled macrophagic CLSs exhibited a significant and positive correlation with markers of hepatocellular injury (ALT and AST) and histological features of MASH (Fig. 3E to H).